Enrich and detect CTCs of prostate cancer from blood

Enrich and detect CTCs of prostate cancer from blood

Anatomy - Pathology

March 01, 2017

Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. In prostate cancer, the expression of three tumor-associated transcripts, prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA) and epidermal growth factor receptor (EGFR), are often altered and used as biomarkers.

In addition, cell surface PSMA presents a unique target for treatment of patients early in their development of prostatic metastases.
How can you detect PSMA, PSA and EGFR in prostate cancer from blood? Learn more

 

 

Cytokine storm in COVID-19 research

Cytokine storm in COVID-19 research

Anatomy - Pathology

New research is rapidly accumulating around cytokine storms as a key biological response to SARS-CoV-2 infection. Get more information and learn about products associated with this process.

May 05, 2020 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us